Form 4: Cardlytics Director Jonathan Edward Francis Acquires 4,310 Shares Through RSU Vesting

Director Jonathan Edward Francis acquired 4,310 shares of Cardlytics, Inc. common stock through the vesting of restricted stock units.

Summary

• Jonathan Edward Francis, a director at Cardlytics, Inc., acquired 4,310 shares of common stock on January 1, 2025.
• The acquisition resulted from the vesting of restricted stock units (RSUs).
• The RSUs were granted on January 1, 2024, and vested in full on the one-year anniversary of the grant date.
• Each RSU represents the right to receive one share of Cardlytics common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally to slightly positive as it aligns director interests with shareholders.

Positives

• The vesting of RSUs indicates a long-term commitment by the director to the company's success.
• The acquisition of shares increases the director's stake in the company.

Industry Context

This is a standard transaction for a director of a public company, where equity compensation is a common practice.

Comparison to Industry Standards

• The vesting of RSUs is a common form of equity compensation for directors and executives in publicly traded companies.
• The one-year vesting period is also a typical timeframe for such grants.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with the company's performance.

Key Dates

Keywords

Cardlytics, Director, Jonathan Edward Francis, RSU, Restricted Stock Units, Share Acquisition, Vesting, Common Stock